FDA Approves Combo Drug for Metastatic Gastric Cancer FDA Approves Combo Drug for Metastatic Gastric Cancer

There is now a new option for patients with metastatic gastric cancer who stop responding to other systemic therapies.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news